We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





SHERLOCK, DETECTR, CAMERA: Three New CRISPR Technologies

By CLN Stat
Posted on 27 Jun 2018
Print article
Scientists in three studies describe how they harnessed CRISPR enzymes to develop or improve upon technology that hunts for genetic sequences linked to viruses or cancer, or capture a cell’s history. Results from all three discoveries appeared in the journal Science.

Two of the studies conducted respectively by CRISPR pioneers Jennifer Doudna, PhD, and Feng Zhang, PhD, looked beyond Cas9, a CRISPR enzyme that’s received a lot of attention for its ability to slice doubled-stranded DNA in specific areas, zeroing in on other types of enzymes as DNA sleuthing tools. Zhang’s study discusses how he and other inventors of the Specific High Sensitivity Reporter unLOCKing, or SHERLOCK, tool were able to expand its target capacity and sensitivity and refine a test format for specific use in disease outbreaks.

SHERLOCK uses a CRISPR-associated protein known as Cas13 which binds to nucleic acid material to find specific targets such as a virus or tumor DNA. Researchers developed a “version 2.0” of SHERLOCK that uses not one but three Cas13 enzymes and one Cas12a enzyme so that it senses multiple targets such as dengue and Zika virus in a single reaction. To enhance SHERLOCK’s capacity for field use, Zhang and his colleagues leveraged technology similar to pregnancy tests to create a paper test that displays results for a single genetic signature. Users dip the paper strip into a processed sample and wait for a line to appear. “The new paper readout for SHERLOCK lets you see whether your target was present in the sample, without instrumentation,” said the study’s co-first author Jonathan Gootenberg in a statement. This innovation means a field-ready diagnostic could be on the horizon for use in outbreak situations.

The SHERLOCK team also combined Cas13 with CRISPR enzyme Csm6 to increase the tool’s sensitivity by threefold. In the study, they were able to find cancer mutations in cell-free DNA from saliva samples. All of these improvements “now give us even more diagnostic information and put us closer to a tool that can be deployed in real-world applications,” said senior author Zhang, core institute member at the Broad Institute and investigator at the McGovern Institute for Brain Research at Massachusetts Institute of Technology.

Doudna, a member of the departments of Molecular and Cell Biology and Chemistry at the University of California-Berkeley, the Howard Hughes Medical Institute, and Lawrence Berkeley National Lab, and her team discovered a new behavior about CRISPR enzyme Ca12, which works similarly to Ca9 in that it uses RNA as a guide to target specific DNA. Once it recognizes its target DNA, however, Ca12 begins to cut single stranded as well as double stranded DNA. “Because this single-strand DNA threading activity is only unleashed after target binding, it can be used as an indicator of the presence of a certain target,” Science editors explained in a summary of the study’s results.

Researchers used this discovery to create a nucleic acid detection technology platform known as the DNA Endonuclease Targeted CRISPR Trans Reporter, or DETECTR. The platform combines Cas12a, its guide RNA, a fluorescent reporter molecule, and recombinase polymerase amplification to create a single reaction. “When warmed to body temperature, RPA rapidly multiplies the number of copies of the target DNA, boosting the chances Cas12a will find one of them, bind and unleash single-strand DNA cutting, resulting in a fluorescent readout,” according to a statement from UC Berkeley.

When applied to patient samples containing human papillomavirus (HPV), DETECTR was able to successfully distinguish between HPV types 16 and 18. This illustrates how sensitive and precise the test is, its authors concluded. “We want to push the limits of the technology, which is potentially applicable in any point-of-care diagnostic situation where there is a DNA component, including cancer and infectious disease,” said study author Janice Chen, a graduate student at Doudna’s lab.

In a third study, researchers Weixin Tang and David Liu, PhD, leveraged Cas9’s target and slice abilities to develop two types of cell data recorders known as CRISPR-mediated analog multi-event recording apparatus or CAMERA systems.

One of the approaches, CAMERA 1, targets cell plasmids, then monitors plasmid ratios of live bacteria cells over time, recording the history of a live bacterial cell’s exposure to nutrients, antibiotics, and other stimuli. Specifically, it records signals by changing the ratio of two DNA plasmids (A and B) in bacterial cells, using Cas9 and a guide RNA to selectively target and destroy just one of the plasmids. In the event A is destroyed, “the result is that the cell starts to replicate both A and B to fill in the loss of A. As a result, the ratio of A:B decreases over time. The more intense the signal, or the longer the signal, the lower this ratio drops,” Liu told CLN Stat.

Another approach, CAMERA 2, records signals by linking a signal of interest to the production of a base editor, “which in turn records the signal directly as a change in the DNA sequence at a specified position in the genome or in plasmid DNA,” Liu said. It works in both bacteria and in mammalian cells.

Liu said his team was able to demonstrate the ability of CAMERA 1 and 2 to record a cell’s exposure to nutrients, antibiotics, light, viruses, and even a kinase inhibitor that changes Wnt signaling in human cells. His and other labs are in the process of using the CAMERA system to study cell signaling during differentiation and other events marked by dramatic changes in cell states.



Visit AACC 2018 >>


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.